Loading...
Adalimumab
India Pharmaceutical Trade Intelligence
Who Supplies Adalimumab to India from UNITED KINGDOM
India's adalimumab imports from UNITED KINGDOM total $28.5K across 5 shipments from 4 foreign suppliers. XXPHAXX LTX leads with $21.6K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include HETERO BIOPHARMA LIMITED. This corridor reflects India's pharmaceutical import demand for adalimumab — a diversified sourcing base with multiple active suppliers from UNITED KINGDOM.
Top foreign suppliers (UNITED KINGDOM) — Ranked by import value
XXPHAXX LTX is the leading Adalimumab supplier from UNITED KINGDOM to India, with import value of $21.6K across 1 shipments. The top 5 suppliers — XXPHAXX LTX, E PHARM LIMITED, ABCAM SINGAPORE PTE LTD, ichorbio Ltd — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (UNITED KINGDOM)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | XXPHAXX LTX | $21.6K | 1 | 75.8% |
| 2 | E PHARM LIMITED | $4.0K | 2 | 13.9% |
| 3 | ABCAM SINGAPORE PTE LTD | $2.4K | 1 | 8.4% |
| 4 | ichorbio Ltd | $551 | 1 | 1.9% |
Showing top 4 of 4 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from UNITED KINGDOM)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | HETERO BIOPHARMA LIMITED | $21.6K | 1 | 75.8% |
| 2 | MSN LABORATORIES PRIVATE LIMITED | $4.0K | 2 | 13.9% |
| 3 | NULIFE CONSULTANTS AND DISTRIBUTORS PRIVATE LIMITE | $2.4K | 1 | 8.4% |
| 4 | KRISHGEN BIOSYSTEMS | $551 | 1 | 1.9% |
Import Statistics
- Import Value
- $28.5K
- Shipments
- 5
- Foreign Suppliers
- 4
- Indian Buyers
- 4
- Avg. Shipment
- $5.7K
Other Adalimumab Import Origins
Related Analysis
Frequently Asked Questions — Adalimumab Imports from UNITED KINGDOM
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Adalimumab suppliers from UNITED KINGDOM to India?
The top Adalimumab suppliers from UNITED KINGDOM to India include XXPHAXX LTX, E PHARM LIMITED, ABCAM SINGAPORE PTE LTD. The leading supplier is XXPHAXX LTX with import value of $21.6K USD across 1 shipments. India imported Adalimumab worth $28.5K USD from UNITED KINGDOM in total across 5 shipments.
QHow much Adalimumab does India import from UNITED KINGDOM?
India imported Adalimumab worth $28.5K USD from UNITED KINGDOM across 5 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Adalimumab from UNITED KINGDOM?
The main Indian buyers of Adalimumab sourced from UNITED KINGDOM include HETERO BIOPHARMA LIMITED, MSN LABORATORIES PRIVATE LIMITED, NULIFE CONSULTANTS AND DISTRIBUTORS PRIVATE LIMITE. The largest buyer is HETERO BIOPHARMA LIMITED with $21.6K in imports across 1 shipments.
QWhat is the total value of Adalimumab imports from UNITED KINGDOM to India?
The total value of Adalimumab imports from UNITED KINGDOM to India is $28.5K USD, across 5 shipments and 4 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: UNITED KINGDOM to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Adalimumab.
- 2.Supplier/Buyer Matching: 4 foreign suppliers from UNITED KINGDOM and 4 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $28.5K aggregated from 5 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
5 Verified Shipments
4 suppliers, 4 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists